Nurx Overview

  • Founded

  • 2014

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 235

Employees
  • Latest Deal Type

  • M&A

Nurx General Information

Description

Operator of a medication prescription and delivery platform intended to put women in control of their own health. The company's platform allows users to request medications such as birth control, sexual health, and more complex conditions including migraine care and dermatology as well as get delivery without the need to visit a doctor, or hospital, or consult any medical professional, enabling women to have convenient, affordable, and personalized care powered by provider specialization and proprietary technology.

Contact Information

Website
www.nurx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Clinics/Outpatient Services
Parent Company
Thirty Madison
Primary Office
  • 548 Market Street
  • Suite 94061
  • San Francisco, CA 94104-5401
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 01-Feb-2022 00000 Completed Generating Revenue
9. Debt - General 31-Dec-2020 0000 00000 Completed Generating Revenue
8. Later Stage VC (Series C) 11-Aug-2020 0000 00000 00000 Completed Generating Revenue
7. Mezzanine 05-Nov-2019 0000 00000 Completed Generating Revenue
6. Later Stage VC 09-Aug-2019 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 30-May-2019 0000 000.00 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 06-Dec-2017 000.00 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Nov-2016 00.00 00.000 000.00 Completed Generating Revenue
2. Accelerator/Incubator 22-Mar-2016 $120K $120K 00.000 Completed Startup
1. Angel (individual) 15-Sep-2015 Completed Startup
To view Nurx’s complete valuation and funding history, request access »

Nurx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C-1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.00
Series A-3 000,000 00.000000 00.00 00.00 00 00.00 0.00
Series A-2 745,944 $0.000010 $0.37 $0.37 1x $0.37 1.69%
Series A-1 4,081,144 $0.000010 $1.18 $1.18 1x $1.18 9.27%
To view Nurx’s complete cap table history, request access »

Nurx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a medication prescription and delivery platform intended to put women in control of their own health. The co
Other Pharmaceuticals and Biotechnology
San Francisco, CA
235 As of 2022
00000
000000&0 00000

00

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
000000000000000000 00000000
New York, NY
000 As of 0000
00.000
0.00 0000-00-00
00000000000 00.000

0000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000000 00000000
Pacific Palisades, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nurx Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ro Venture Capital-Backed New York, NY 000 00.000 00000000000 00.000
0000 Venture Capital-Backed Pacific Palisades, CA 000 00000 00000000000 00000
00000 000000 Venture Capital-Backed Toronto, Canada 00 000.00 0000000000 0 000.00
0000000000 Formerly VC-backed Oakland, CA 00 00.000 000000&0 00.000
00000 Venture Capital-Backed New York, NY 000 00000 00000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Nurx Executive Team (12)

Name Title Board Seat Contact Info
Edvard Engesaeth MD Co-Founder, Innovation Officer & Board Member
You’re viewing 1 of 12 executive team members. Get the full list »

Nurx Board Members (5)

Name Representing Role Since
Andrew Weissman JD Union Square Ventures Board Member 000 0000
Chelsea Clinton Ph.D Clinton Foundation Board Member 000 0000
Edvard Engesaeth MD Nurx Co-Founder, Innovation Officer & Board Member 000 0000
Noah Knauf Kleiner Perkins Board Member 000 0000
Regina Benjamin Self Board Member 000 0000
To view Nurx’s complete board members history, request access »

Nurx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurx Former Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Venture Capital Minority 000 0000 000000 0
CSC UpShot Ventures Venture Capital Minority 000 0000 000000 0
Clinton Foundation Impact Investing Minority 000 0000 000000 0
Comcast Ventures Corporate Venture Capital Minority 000 0000 000000 0
Dan Knox Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 33 investors. Get the full list »

Ready to get started?

Request a free trial